I’ll have more on this over the weekend, but Merck’s lawyers are deep into motion practice — before Judge Keenan in Manhattan’s federal District Court — in the Fosamax® MDL. Merck is seeking an expansion of the sorts of claims to which so-called Lone Pine procedures would apply.
So stay tuned, here — more after a hectic Friday largely off the grid:
. . . .Entered August 5, 2013 | Cause 06-1789 | Oral Argument: August 12, 2013 10:30 AM EDT. . .